# FibroGen, Inc. (KYNB) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$46M |
| 2024 | -$150M |
| 2023 | -$323M |
| 2022 | -$301M |
| 2021 | -$289M |
| 2020 | -$192M |
| 2019 | -$89M |
| 2018 | -$87M |
| 2017 | -$117M |
| 2016 | -$50M |
| 2015 | -$78M |
| 2014 | -$50M |
| 2013 | -$8M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$14M |
| 2025-09-30 | -$5M |
| 2025-06-30 | -$12M |
| 2025-03-31 | -$15M |
| 2024-09-30 | -$48M |
| 2024-06-30 | -$46M |
| 2024-03-31 | -$49M |
| 2023-09-30 | -$63M |
| 2023-06-30 | -$88M |
| 2023-03-31 | -$76M |
| 2022-09-30 | -$94M |
| 2022-06-30 | -$78M |
| 2022-03-31 | -$63M |
| 2021-09-30 | $51M |
| 2021-06-30 | -$134M |
| 2021-03-31 | -$70M |
| 2020-09-30 | $32M |
| 2020-06-30 | -$85M |
| 2020-03-31 | -$81M |
| 2019-09-30 | -$53M |
| 2019-06-30 | $113M |
| 2019-03-31 | -$49M |
| 2018-09-30 | -$43M |
| 2018-06-30 | -$23M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/KYNB/operating-income)